15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Influenza vaccination coverage among US-Mexico land border crossers: 2009 H1N1 pandemic and 2011–2012 influenza season

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          The high volume of US-Mexico land border crossings can facilitate international dissemination of influenza viruses.

          Methods:

          We surveyed adult pedestrians crossing into the United States at two international land ports of entry to assess vaccination coverage during the 2009H1N1 influenza pandemic and 2011–2012 influenza season.

          Results:

          Of 559 participants in 2010, 23.4% reported receipt of the 2009H1N1 vaccine. Of 1423 participants in 2012, 33.7% received the 2011–2012 influenza vaccine. Both years, those crossing the border ≥8 times per month had lower vaccination coverage than those crossing less frequently. US-border residents had lower H1N1 coverage than those in other locations. Vaccination coverage was higher for persons age ≥65 years and, in 2010 only, those with less than high school education. Although most participants believed it is important to get vaccinated, only half believed the influenza vaccine was safe and effective. The main reasons for not receiving the influenza vaccine were beliefs of low risk of disease, time constraints, and concerns about vaccine safety (in 2010) or efficacy (in 2012).

          Conclusions:

          International land border crossers are a large and unique category of travelers that require targeted binational strategies for influenza vaccination and education.

          Related collections

          Author and article information

          Journal
          101230758
          33012
          Travel Med Infect Dis
          Travel Med Infect Dis
          Travel medicine and infectious disease
          1477-8939
          1873-0442
          3 May 2019
          06 October 2018
          Jan-Feb 2019
          01 January 2020
          : 27
          : 99-103
          Affiliations
          [a ]Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
          [b ]Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA
          [c ]Division of Vector-borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
          [d ]Karna LLC, Atlanta, GA, USA
          [e ]SWOG, Virginia Commonwealth University, San Antonio, TX, USA
          [f ]Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
          Author notes

          Author contributions

          SW and AR conceived and designed the study. AR and CD analyzed and interpreted the data. AR drafted the manuscript. All authors critically revised the manuscript for important intellectual content. SW supervised the study.

          [* ]Corresponding author. Centers for Disease Control and Prevention, 3851 Rosecrans St., MS P575, San Diego, CA, 92110, USA. jqi3@ 123456cdc.gov (A. Rodriguez-Lainz).
          Article
          PMC6532778 PMC6532778 6532778 hhspa1027261
          10.1016/j.tmaid.2018.10.002
          6532778
          30296482
          807bb74a-b5e1-4a33-986e-881d235bab39
          History
          Categories
          Article

          Border crossers,US-Mexico border,Vaccination,H1N1 subtype,Influenza A virus

          Comments

          Comment on this article